$PSGR A quick review of March shows that Pershing Resources
$PSGR A quick review of March shows that Pershing Resources issued THREE Press Releases. Yep, remarkable as this sounds, all THREE Press Releases said absolutely NOTHING about whether or not the mining properties/claims have REAL value. Sure, in the past there have been reported assays that indicated that there were some limited locations that had a reportable amount of precious metals present. What continues to be odd about the reported assays is that NOTHING has ever been done about extracting the gold from the ore that is alleged to be on the mine sites/claims.
Think about this: You have told your out-of-state family members that you have orange trees, lemon trees, apple trees and cherry trees in your back yard. Since they do not know precisely where you live, they have NEVER seen the trees. Each holiday period, you promise to send family members a basket of FRESH FRUIT. Each holiday period you send NOTHING, then tell your family that: 1) The equipment broke down /OR/ 2) The laborers (pickers) never showed up /OR/ 3) The fruit was on the trees but it was not quite ready to pick /OR/ 4) You tell your family that you bought some more land that you think will produce even more fruit than the current location......and you make no further mention of the existing fruit trees.
Sound familiar????
I am POSITIVE that MY one LEMON TREE has fruit. I won't send you any fruit BUT I have lots of pictures of the tree and the lemons and the juice that I extracted from the fruit. AND....I am not even an arborist!!! Let's see.....1) Plant the tree....everyone can see the tree 2) Water/fertilize the tree...everyone can see it grow 3) Wait for the flowers/buds to appear...everyone can see the foliage 4) Watch as the small lemons start growing....everyone can see the small lemons 5) Wait for lemons to mature then pick....everyone can see and smell and touch the lemons 6) Sell, trade, or giveaway several dozen lemons or make lemon juice....everyone can enjoy the results
I suppose the differences between my Lemon Tree and the mines/claims that we read so much about is that my Lemon Tree
1) NEVER moves 2) Produces a product 3) Can be profitable IF I choose to sell any lemons 4) Can be seen or touched whenever someone wants to see what/how it is doing 5) Only needs water and fertilizer...honest-to-God, straight from the cattle yard BS is good fertilizer; VERBAL BS has yet to cause any change in the Lemon Tree. Hmmmmm, we may have identified the possible source of the precious metals conundrum!
Pershing Resources Company Inc. (PSGR) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...
Continue Reading
New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...
Continue Reading
Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...
Continue Reading
Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...
Continue Reading
Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...
Continue Reading
Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...
Continue Reading
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Top 5 Most Recently Viewed Articles
Remarkable Surge of Australian Oilseeds Holdings Shares of Australian Oilseeds Holdings Ltd. (NASDAQ: COOT) experienced an astonishing increase, rising 248.19% in after-hours trading. Following this surge, the stock closed at an impressive $3.36, marking a significant shift in investor interest. Political Factors Influencing Market Movements Recently, political activities...
Continue Reading
EIB Submits SEC Form 18-K/A Amendment No. 4 On a recent date, the European Investment Bank (EIB) took a significant step by submitting SEC Form 18-K/A Amendment No. 4. This submission provides important updates regarding the bank's financial status and operations for the first half of the year. Understanding the Importance of This Submission This amendment is particularly...
Continue Reading
Understanding the Impact of Unmanaged Contracts on Business Workday's recent research sheds light on a pressing issue affecting businesses today: unmanaged contracts. The study highlights that a staggering 76% of employees are unclear about who is responsible for contract ownership, leading to lost revenue and overlooked opportunities. Contracts serve a crucial role in...
Continue Reading
Understanding the Legal Landscape for PubMatic, Inc. Recently, there has been considerable attention on PubMatic, Inc. This attention arises from a legal investigation by prominent law firm Pomerantz LLP aimed at examining claims on behalf of investors of the company. The Investigation Details Pomerantz LLP has taken a proactive stance in uncovering whether PubMatic and...
Continue Reading
DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...
Continue Reading